Jefferies Group Comments on Sabra Healthcare REIT, Inc.’s Q1 2018 Earnings (SBRA)

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) – Research analysts at Jefferies Group issued their Q1 2018 earnings estimates for Sabra Healthcare REIT in a report issued on Tuesday. Jefferies Group analyst O. Okusanya expects that the real estate investment trust will post earnings of $0.62 per share for the quarter. Jefferies Group has a “Buy” rating and a $25.00 price objective on the stock. Jefferies Group also issued estimates for Sabra Healthcare REIT’s Q2 2018 earnings at $0.62 EPS, Q3 2018 earnings at $0.63 EPS, Q4 2018 earnings at $0.63 EPS, Q1 2019 earnings at $0.64 EPS and Q2 2019 earnings at $0.64 EPS.

ILLEGAL ACTIVITY WARNING: “Jefferies Group Comments on Sabra Healthcare REIT, Inc.’s Q1 2018 Earnings (SBRA)” was originally published by Community Financial News and is owned by of Community Financial News. If you are accessing this piece of content on another publication, it was stolen and republished in violation of US and international copyright and trademark laws. The correct version of this piece of content can be read at https://www.com-unik.info/2017/08/18/jefferies-group-comments-on-sabra-healthcare-reit-inc-s-q1-2018-earnings-sbra.html.

Other equities research analysts have also issued research reports about the company. Mizuho lowered Sabra Healthcare REIT from a “neutral” rating to an “underperform” rating and cut their target price for the stock from $25.00 to $23.00 in a research report on Monday, July 10th. BidaskClub raised Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research report on Tuesday, June 20th. Canaccord Genuity reaffirmed a “hold” rating and set a $26.00 price target on shares of Sabra Healthcare REIT in a research report on Tuesday, May 9th. Stifel Nicolaus reaffirmed a “hold” rating and set a $26.00 price target on shares of Sabra Healthcare REIT in a research report on Friday, July 28th. Finally, Zacks Investment Research raised Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research report on Tuesday, July 11th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and an average target price of $27.00.

Sabra Healthcare REIT (SBRA) traded down 0.52% during trading on Wednesday, hitting $21.07. 637,686 shares of the stock traded hands. Sabra Healthcare REIT has a 12 month low of $19.30 and a 12 month high of $29.10.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Zurcher Kantonalbank Zurich Cantonalbank raised its position in Sabra Healthcare REIT by 14.2% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,799 shares of the real estate investment trust’s stock worth $106,000 after buying an additional 471 shares during the last quarter. Bank of Montreal Can raised its position in Sabra Healthcare REIT by 44.1% in the first quarter. Bank of Montreal Can now owns 3,893 shares of the real estate investment trust’s stock worth $109,000 after buying an additional 1,191 shares during the last quarter. Russell Investments Group Ltd. bought a new position in Sabra Healthcare REIT during the fourth quarter worth about $120,000. Ameritas Investment Partners Inc. bought a new position in Sabra Healthcare REIT during the first quarter worth about $156,000. Finally, Daiwa Securities Group Inc. raised its position in Sabra Healthcare REIT by 15.7% in the second quarter. Daiwa Securities Group Inc. now owns 5,900 shares of the real estate investment trust’s stock worth $142,000 after buying an additional 800 shares during the last quarter. 99.26% of the stock is currently owned by institutional investors and hedge funds.

The business also recently announced a dividend, which will be paid on Friday, August 18th. Stockholders of record on Wednesday, August 16th will be issued a $0.3599 dividend. The ex-dividend date of this dividend is Monday, August 14th. Sabra Healthcare REIT’s payout ratio is currently 145.76%.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.

Earnings History and Estimates for Sabra Healthcare REIT (NASDAQ:SBRA)

What are top analysts saying about Sabra Healthcare REIT Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Sabra Healthcare REIT Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit